Rev Cardiovasc Med

Q: 如果Rev Cardiovasc Med在你的國家或地區不可用，應該如何下載？

點擊<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">此處</a>瞭解如何在受限國家或地區下載Rev Cardiovasc Med。

Q: 運行Rev Cardiovasc Med的最低配置要求是什麼？

以下為Rev Cardiovasc Med的最低配置要求。<br/><ul><li>iPhone-</li><li>iPad-</li></ul>

Free

25732388for iPhone, iPad

MedReviews

Developer

2018年12月06日

Update Date

Medical

Category

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Rev Cardiovasc Med 螢幕截圖

iPad

iPhone

About Rev Cardiovasc Med

Reviews in Cardiovascular Medicine is designed to review the latest advances in the diagnosis and treatment of a wide range of cardiovascular conditions to help the busy, practicing cardiologist keep up to date with the rapidly evolving field of cardiology. Reviews in Cardiovascular Medicine is targeted to practicing cardiologists in the United States.

Topics featured include cardiorenal function, coagulation/thrombosis, congestive heart failure, diabetic cardiovascular disease, echocardiography heart disease, electrophysiology, hypertension, interventional cardiology, ischemic heart disease, lipid disorders, molecular cardiobiology, new drugs and devices, nuclear cardiology, peripheral vascular medicine, renal dysfunction, valvular heart disease, women and heart disease